Ledger.Open graph →
SEC Form D · filed June 15, 2016

Akriveia Therapeutics, LLC

Offering
$7.5M
Sold
$4.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SKILLMAN, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Benjamin Auspitz · Skillman, NJDirectorThomas Beck · Skillman, NJDirectorSimon Tomlinson · Skillman, NJExec · DirectorEric D. Rea · Lehi, UTDirectorModulus Capital Management, LP · Bellaire, TXDirectorEric M. Strzempek · Bloomfield Hills, MIExec · DirectorErnest J. Morrison · Hamilton, BermudaDirectorPunit Dhillon · San Diego, CADirectorAvtar Dhillon · San Diego, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗